The World Bank pioneered global HIV and AIDS financing early in the emergency and remains committed to achieving Millennium Development Goal 6, to halt by 2015 and begin to reverse the spread of HIV and AIDS, through prevention, care, treatment, and mitigation services for those affected by HIV and AIDS.
Read More »

Niger's morbidity and mortality
statistics are dominated by communicable diseases while
there is until now a relatively low burden of disease
attributable to non-communicable... Show More + diseases. Despite Niger
being a low human immunodeficiency virus (HIV) prevalence
and comparatively low HIV and acquired immunodeficiency
syndrome (AIDS) burden country, HIV and AIDS is an emerging
and significant cause of disability adjusted life year
(DALYs) since recent years. Better implementing,
integrating, and allocating resources has the potential of
saving time and money, and freeing up resources to address
other key development challenges in Niger. The overarching
objective is to provide the Government of Niger with a
comprehensive investment case analysis on HIV financing
needs and investment opportunities in the context of burden
of disease priorities, health financing, and health system
strengthening, in order to inform a HIV response which is
efficient, impactful, cost-effective, and financially
sustainable. Such an analysis supports decision-making on
HIV policy options, investment scenarios, and programmatic
targeting and prioritization. It also helps Niger make the
case for investment for HIV and health impact, and provides
estimates of health care savings. A financial commitment
framework was used to estimate longer-term costs and savings
of the HIV program and the fiscal dimension of HIV in Niger.
In this context, this report is organized as follows:
section one gives introduction. Section two gives
development context, health priorities, and health system
challenges in Niger. Section three presents the state of the
HIV epidemic. Section four presents HIV financing, services
and programs, and their efficiency. Section five focuses on
impacts from past HIV expenditures and best resource
allocations in the current strategic plan period. Section
six deals with financing needs and fiscal space implications
of HIV investments. Show Less -